国产亚洲AV综合人人澡小说_国产精品免费午夜在线a_国产成人免费观看视频_国产精品国产午夜免费看福利_一区二区三区日韩_撕开丝袜直顶而入在线视频_波多结依无码观看_无遮挡一级毛片私人影院_欧美日韩在线视频专区_国产一级九九久久毛片精品
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.03.06
2018年第二次臨時(shí)股東大會(huì)決議公告
2018.03.03
關(guān)于公司和全資孫公司共同對(duì)外投資完成的公告
2018.02.27
2017年度業(yè)績(jī)快報(bào)
2018.02.13
關(guān)于召開(kāi)2018年第二次臨時(shí)股東大會(huì)通知的更正公告
2018.02.13
華融證券股份有限公司關(guān)于公司公開(kāi)發(fā)行2016年公司債券重大事項(xiàng)受托管理事務(wù)臨時(shí)報(bào)告
2018.02.12
關(guān)于公司與Aridis設(shè)立合資子公司的公告
2018.02.12
關(guān)于2018年度日常經(jīng)營(yíng)性關(guān)聯(lián)交易預(yù)計(jì)的公告
2018.02.12
第四屆董事會(huì)第十一次會(huì)議決議公告
2018.02.12
第四屆監(jiān)事會(huì)第七次會(huì)議決議公告
2018.02.12
關(guān)于收購(gòu)深圳市多普樂(lè)實(shí)業(yè)發(fā)展有限公司100%股權(quán)之方案調(diào)整的說(shuō)明
第一頁(yè)
上一頁(yè)
60
61
62
63
64
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.